Tesla To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Monday
Bristol-Myers Squibb Analyst Ratings
Jefferies Upgrades Bristol-Myers Squibb(BMY.US) to Buy Rating, Raises Target Price to $70
Jefferies Upgrades Bristol-Myers Squibb to Buy From Hold, Adjusts Price Target to $70 From $63
Bristol-Myers Squibb (NYSE:BMY) Will Pay A Larger Dividend Than Last Year At $0.62
Bristol-Myers Squibb Notified Century Therapeutics On Dec 12 To Terminate Collaboration Agreement, Effective March 12, 2025; Co To Evaluate Opportunities In AML And Multiple Myeloma In The Context Of The Ongoing Strategic Review Of Century's...
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Alwayslearning5 : LOL